PURPOSE: To explore the frequency of CAM use among hypertensive patients in Palestine, determine demographic characteristics that may increase the likelihood of CAM use and to find out how benefits were perceived by patients. METHODS: Across-sectional survey of patients attending outpatient hypertension clinics. The method was based on a semi-structured questionnaire. RESULTS: Of the 4575 hypertensive patients interviewed, 85.7% respondents used at least one type of CAM. Of the 3921 CAM users, 62.13% reported taking herbs. Most of these users were >50 years old, of low educational level, and had a family history of HTN, 62.9% claimed to have obtained the desired effect from taking these herbs; however, 68.1% did not disclose this fact to their health care providers, 83 plant taxa were reported by these patients, Allium sativum was the most commonly used herb. CONCLUSIONS: The use of CAM, particularly herbal therapies for hypertension treatment, is highly prevalent in Palestine.
PURPOSE: To explore the frequency of CAM use among hypertensivepatients in Palestine, determine demographic characteristics that may increase the likelihood of CAM use and to find out how benefits were perceived by patients. METHODS: Across-sectional survey of patients attending outpatienthypertension clinics. The method was based on a semi-structured questionnaire. RESULTS: Of the 4575 hypertensivepatients interviewed, 85.7% respondents used at least one type of CAM. Of the 3921 CAM users, 62.13% reported taking herbs. Most of these users were >50 years old, of low educational level, and had a family history of HTN, 62.9% claimed to have obtained the desired effect from taking these herbs; however, 68.1% did not disclose this fact to their health care providers, 83 plant taxa were reported by these patients, Allium sativum was the most commonly used herb. CONCLUSIONS: The use of CAM, particularly herbal therapies for hypertension treatment, is highly prevalent in Palestine.
Authors: Sa'ed H Zyoud; Samah W Al-Jabi; Waleed M Sweileh; Ghada H Tabeeb; Nora A Ayaseh; Mayas N Sawafta; Razan L Khdeir; Diana O Mezyed; Dala N Daraghmeh; Rahmat Awang Journal: BMC Complement Altern Med Date: 2016-07-11 Impact factor: 3.659
Authors: Rana M Jamous; Salam Y Abu-Zaitoun; Rola J Akkawi; Mohammed S Ali-Shtayeh Journal: Evid Based Complement Alternat Med Date: 2018-06-13 Impact factor: 2.629
Authors: Naser Y Shraim; Ramzi Shawahna; Muna A Sorady; Banan M Aiesh; Ghadeer Sh Alashqar; Raghad I Jitan; Waed M Abu Hanieh; Yasmeen B Hotari; Waleed M Sweileh; Sa'ed H Zyoud Journal: BMC Complement Altern Med Date: 2017-08-29 Impact factor: 3.659